Effective January 1, 2019, Horizon Blue Cross Blue Shield of New Jersey will no longer administer Medicare Advantage (MA) PPO plans for the New Jersey State Health Benefits Program (SHBP).
On March 2, 2018, Biogen and AbbVie announced the voluntary worldwide withdrawal of Zinbryta® (daclizumab), a medicine used to treat relapsing multiple sclerosis.
If an electronic claim is rejected, you will receive an error report, either the 999 or the 277CA Claims Acknowledgement Report that explains why the claim was rejected.
Horizon BCBSNJ is aware of an EFT issue that is resulting in the display of duplicate Explanation of Payment (EOP) statements within NaviNet’s Payment Status inquiry transaction for payments November 3, 2016 and after.
Remember to sign in to NaviNet to check patient eligibility, status of a claim and more.
